Cerebral metabolism as measured with positron emission tomography [PET] and[¹⁸F] 2-deoxy-D-glucose: healthy aging, Alzheimer's disease and down syndromeCUTLER, N. R.Progress in neuro-psychopharmacology & biological psychiatry. 1986, Vol 10, Num 3-5, pp 309-321, issn 0278-5846Article

Scientific and ethical concerns in clinical trials in Alzheimer's patients : the bridging studyCUTLER, N. R; SRAMEK, J. J.European journal of clinical pharmacology. 1995, Vol 48, Num 6, pp 421-428, issn 0031-6970Article

Guidelines for conducting bridging studies in Alzheimer diseaseCUTLER, N. R; SRAMEK, J. J.Alzheimer disease and associated disorders. 1998, Vol 12, Num 2, pp 88-92, issn 0893-0341Article

Recent developments in the drug treatment of Alzheimer's diseaseSRAMEK, J. J; CUTLER, N. R.Drugs & aging. 1999, Vol 14, Num 5, pp 359-373, issn 1170-229XArticle

The target population in Phase I clinical trials of cholinergic compounds in Alzheimer disease : the role of the bridging studyCUTLER, N. R; SRAMEK, J. J.Alzheimer disease and associated disorders. 1995, Vol 9, Num 3, pp 139-145, issn 0893-0341Article

The Use of Ethological Principles in Teaching Parent-Child Relations to Elementary School ChildrenCUTLER, N. R; GROSSBERG, G. T; SHOPPER, M et al.Education Chula Vista, Cal. 1978, Vol 98, Num 4, pp 397-402Article

The role of bridging studies in the development of cholinesterase inhibitors for Alzheimer's diseaseCUTLER, N. R; SRAMEK, J. J.CNS drugs. 1998, Vol 10, Num 5, pp 355-364, issn 1172-7047Article

Pharmacotherapy in Alzheimer's disease: basis and rationaleNARANG, P. K; CUTLER, N. R.Progress in neuro-psychopharmacology & biological psychiatry. 1986, Vol 10, Num 3-5, pp 519-531, issn 0278-5846Article

Pharmacokinetic-pharmacodynamic modeling of rivastigmine, a cholinesterase inhibitor, in patients with Alzheimer's diseaseGOBBURU, J. V. S; TAMMARA, V; LESKO, L et al.Journal of clinical pharmacology. 2001, Vol 41, Num 10, pp 1082-1090, issn 0091-2700Article

A treatment and withdrawal trial of besipiridine in Alzheimer diseaseHUFF, F. J; ANTUONO, P. G; SHIPLEY, J. E et al.Alzheimer disease and associated disorders. 1996, Vol 10, Num 2, pp 93-102, issn 0893-0341Article

Effect of the ace inhibitor ceronapril on cerebral blood flow in hypertensive patientsCUTLER, N. R; SRAMEK, J. J; LUNA, A et al.The Annals of pharmacotherapy. 1996, Vol 30, Num 6, pp 578-582, issn 1060-0280Article

Cholinergic rebound and rapid onset psychosis following abrupt clozapine withdrawalSHIOVITZ, T. M; WELKE, T. L; TIGEL, P. D et al.Schizophrenia bulletin. 1996, Vol 22, Num 4, pp 591-595, issn 0586-7614Article

Efficacy and safety of BMY 21,502 in Alzheimer diseaseSHROTRIYA, R. C; CUTLER, N. R; SRAMEK, J. J et al.The Annals of pharmacotherapy. 1996, Vol 30, Num 12, pp 1376-1380, issn 1060-0280Article

The safety and tolerance of xanomeline tartrate in patients with Alzheimer's diseaseSRAMEK, J. J; HURLEY, D. J; WARDLE, T. S et al.Journal of clinical pharmacology. 1995, Vol 35, Num 8, pp 800-806, issn 0091-2700Article

A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorderKRAMER, M. S; CUTLER, N. R; BALLENGER, J. C et al.Biological psychiatry (1969). 1995, Vol 37, Num 7, pp 462-466, issn 0006-3223Article

Salicylate protein binding in serum from young and elderly subjects as measured by diafiltrationLESKO, L. J; NARANG, P. K; YEAGER, L et al.European journal of clinical pharmacology. 1985, Vol 28, Num 3, pp 339-345, issn 0031-6970Article

Effects of chronic desipramine on plasma norepinephrine concentrations and cardiovascular parameters in elderly depressed women: a preliminary reportCUTLER, N. R; ZAVADIL, A. P. III; LINNOILA, M et al.Biological psychiatry (1969). 1984, Vol 19, Num 4, pp 549-556, issn 0006-3223Article

Low-dose apomorphine and bromocriptine in neuroleptic-induced movement disordersJESTE, D. V; CUTLER, N. R; KAUFMANN, C. A et al.Biological psychiatry (1969). 1983, Vol 18, Num 9, pp 1085-1091, issn 0006-3223Article

Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefitGIACOBINI, E; SPIEGEL, R; ENZ, A et al.Journal of neural transmission. 2002, Vol 109, Num 7-8, pp 1053-1065, issn 0300-9564, 13 p.Article

Pharmacokinetics of rizatriptan tablets during and between migraine attacksCUTLER, N. R; JHEE, S. S; MAJUMDAR, A. K et al.Headache. 1999, Vol 39, Num 4, pp 264-269, issn 0017-8748Article

Efficacy of buspirone in generalized anxiety disorder with coexisting mild depressive symptomsSRAMEK, J. J; TANSMAN, M; SURI, A et al.The Journal of clinical psychiatry. 1996, Vol 57, Num 7, pp 287-291, issn 0160-6689Article

Placebo response in anxiety disordersPIERCY, M. A; SRAMEK, J. J; KURTZ, N. M et al.The Annals of pharmacotherapy. 1996, Vol 30, Num 9, pp 1013-1019, issn 1060-0280Article

Dose-ranging study of a new, once-daily diltiazem formulation for patients with stable anginaCUTLER, N. R; FROMELL, G; BRASS, E. P et al.Journal of clinical pharmacology. 1995, Vol 35, Num 2, pp 189-195, issn 0091-2700Article

Oral sumatriptan in preventing headache recurrence after treatment of migraine attacks with subcutaneous sumatriptanRAPOPORT, A. M; VISSER, W. H; CUTLER, N. R et al.Neurology. 1995, Vol 45, Num 8, pp 1505-1509, issn 0028-3878Article

Placebo-controled evaluation of three doses of a controlled-onset, extended-release formulation of verapamil in the treatment of stable angina pectorisCUTLER, N. R; ANDERS, R. J; JHEE, S. S et al.The American journal of cardiology. 1995, Vol 75, Num 16, pp 1102-1106, issn 0002-9149Article